invIOs GmbH, a biotechnology company specializing in cancer therapies, will present updates on its oncology pipeline, including advancements in glioblastoma treatments, during JP Morgan Week 2025 in San Francisco. The company will highlight its collaboration with Dana-Farber Cancer Institute on two innovative approaches: a small molecule therapy and a cell therapy.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.